|
| U.S. Brand
Names |
|
| Riobin® |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Lactoflavin; Vitamin B2; Vitamin G |

|
|
| Pharmacological Index |
|
|
Vitamin, Water Soluble |

|
|
| Use |
|
|
Dental and Medical: Prevent riboflavin deficiency and treat
ariboflavinosis |

|
|
| Pregnancy Risk
Factor |
|
|
A/C (if dose exceeds RDA recommendation) |

|
|
| Warnings/Precautions |
|
|
Riboflavin deficiency often occurs in the presence of other B vitamin
deficiencies |

|
|
| Adverse
Reactions |
|
|
Genitourinary: Discoloration of urine (yellow-orange) |

|
|
| Drug
Interactions |
|
|
Decreased absorption with probenecid |

|
|
| Mechanism of
Action |
|
|
Component of flavoprotein enzymes that work together, which are necessary for
normal tissue respiration; also needed for activation of pyridoxine and
conversion of tryptophan to niacin |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Readily via GI tract, however, food increases extent of GI
absorption; GI absorption is decreased in patients with hepatitis, cirrhosis, or
biliary obstruction
Metabolism: Metabolic fate unknown
Half-life, biologic: 66-84 minutes
Elimination: 9% excreted unchanged in urine |

|
|
| Usual Dosage |
|
|
Oral:
Children: 2.5-10 mg/day in divided doses
Adults: 5-30 mg/day in divided doses
Recommended daily allowance:
Children: 0.4-1.8 mg
Adults: 1.2-1.7 mg |

|
|
| Test
Interactions |
|
|
Large doses may interfere with urinalysis based on spectrometry; may cause
false elevations in fluorometric determinations of catecholamines and
urobilinogen |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None reported |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Take with food. Large doses may cause bright yellow or orange
urine. |

|
|
| Nursing
Implications |
|
|
Monitor CBC and reticulocyte counts (if anemic when treating
deficiency) |

|
|
| Dosage Forms |
|
|
Tablet: 25 mg, 50 mg, 100 mg |

|
|
Copyright © 2007 Drugs Area
|